SK284495B6 - Spôsob výroby triazolyltryptamínových zlúčenín a medziprodukty na vykonávanie tohto spôsobu - Google Patents
Spôsob výroby triazolyltryptamínových zlúčenín a medziprodukty na vykonávanie tohto spôsobu Download PDFInfo
- Publication number
- SK284495B6 SK284495B6 SK1498-96A SK149896A SK284495B6 SK 284495 B6 SK284495 B6 SK 284495B6 SK 149896 A SK149896 A SK 149896A SK 284495 B6 SK284495 B6 SK 284495B6
- Authority
- SK
- Slovakia
- Prior art keywords
- compound
- formula
- group
- palladium
- indol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Inorganic Insulating Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/248,288 US5567824A (en) | 1994-05-24 | 1994-05-24 | Palladium catalyzed ring closure of triazolyltryptamine |
| PCT/US1995/005506 WO1995032197A1 (en) | 1994-05-24 | 1995-05-19 | Palladium catalyzed ring closure of triazolyl tryptamine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK149896A3 SK149896A3 (en) | 1997-09-10 |
| SK284495B6 true SK284495B6 (sk) | 2005-05-05 |
Family
ID=22938473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1498-96A SK284495B6 (sk) | 1994-05-24 | 1995-05-19 | Spôsob výroby triazolyltryptamínových zlúčenín a medziprodukty na vykonávanie tohto spôsobu |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5567824A (ru) |
| EP (1) | EP0763032B1 (ru) |
| JP (1) | JP3947216B2 (ru) |
| KR (1) | KR100385027B1 (ru) |
| CN (2) | CN1157390C (ru) |
| AT (1) | ATE252095T1 (ru) |
| AU (1) | AU688505B2 (ru) |
| DE (1) | DE69531939T2 (ru) |
| DK (1) | DK0763032T3 (ru) |
| ES (1) | ES2207648T3 (ru) |
| FI (1) | FI116899B (ru) |
| HK (2) | HK1009045A1 (ru) |
| HR (1) | HRP950304B1 (ru) |
| HU (1) | HU226460B1 (ru) |
| MX (1) | MX9605838A (ru) |
| NZ (1) | NZ285539A (ru) |
| PT (1) | PT763032E (ru) |
| RO (1) | RO118586B1 (ru) |
| RU (1) | RU2138496C1 (ru) |
| SK (1) | SK284495B6 (ru) |
| TW (1) | TW300221B (ru) |
| UA (1) | UA52586C2 (ru) |
| WO (1) | WO1995032197A1 (ru) |
| YU (1) | YU49345B (ru) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0840733B1 (en) * | 1995-07-11 | 2001-10-24 | Merck & Co., Inc. | A triazolylmethyl-indole ethylamine bisulfate salt |
| ZA965837B (en) * | 1995-07-11 | 1997-01-31 | Merck & Co Inc | A triazolylmethyl-indole ethylamine bisulfate salt |
| US5808064A (en) * | 1996-08-13 | 1998-09-15 | Merck & Co., Inc. | Palladium catalyzed indolization |
| US5811551A (en) * | 1996-08-13 | 1998-09-22 | Merck & Co., Inc. | Palladium catalyzed indolization |
| EP0925302B1 (en) * | 1996-08-13 | 2002-11-20 | Merck & Co., Inc. | Palladium catalyzed indolization |
| US5877329A (en) * | 1996-08-13 | 1999-03-02 | Merck & Co., Inc. | Palladium catalyzed indolization |
| BR0011997A (pt) * | 1999-06-28 | 2002-03-05 | Janssen Pharmaceutica Nv | Inibidores da replicação do vìrus sincicial respiratório |
| ES2204303B2 (es) * | 2002-08-07 | 2004-12-16 | Laboratorios Vita, S.A. | Procedimiento para la obtencion de un compuesto farmaceuticamente activo. |
| EP1709032A2 (en) | 2004-01-09 | 2006-10-11 | Ratiopharm GmbH | Crystalline forms of rizatriptan benzoate |
| US7786156B2 (en) | 2004-01-28 | 2010-08-31 | Ratiopharm Gmbh | Synthesis methods and intermediates for the manufacture of Rizatriptan |
| PA8626701A1 (es) * | 2004-03-26 | 2006-05-16 | Wyeth Corp | Procedimientos para la preparacion de compuestos aminoarilos yodados |
| WO2006082598A2 (en) * | 2005-02-01 | 2006-08-10 | Natco Pharma Limited | Novel crystalline forms of rizatriptan benzoate |
| WO2006137083A1 (en) * | 2005-06-20 | 2006-12-28 | Natco Pharma Limited | Improved process for the preparation of rizatriptan benzoate |
| WO2007054979A1 (en) * | 2005-11-14 | 2007-05-18 | Matrix Laboratories Ltd | Process for the large scale production of rizatriptan benzoate |
| WO2007083320A2 (en) * | 2006-01-19 | 2007-07-26 | Matrix Laboratories Ltd | Conversion of aromatic diazonium salt to aryl hydrazine |
| US20100256208A1 (en) * | 2007-06-04 | 2010-10-07 | Gore Vinayak G | Novel process |
| EP3407869A1 (en) | 2016-01-27 | 2018-12-05 | Instar Technologies A.S. | Oromucosal nanofiber carriers for therapeutic treatment |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK278998B6 (sk) * | 1991-02-01 | 1998-05-06 | Merck Sharp & Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu, spôsob i |
| CA2084531A1 (en) * | 1991-12-19 | 1993-06-20 | David W. Smith | Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines |
| GB9215526D0 (en) * | 1992-07-22 | 1992-09-02 | Merck Sharp & Dohme | Chemical process |
-
1994
- 1994-05-24 US US08/248,288 patent/US5567824A/en not_active Expired - Lifetime
-
1995
- 1995-05-16 TW TW084104806A patent/TW300221B/zh not_active IP Right Cessation
- 1995-05-19 EP EP95918939A patent/EP0763032B1/en not_active Expired - Lifetime
- 1995-05-19 ES ES95918939T patent/ES2207648T3/es not_active Expired - Lifetime
- 1995-05-19 DE DE69531939T patent/DE69531939T2/de not_active Expired - Lifetime
- 1995-05-19 JP JP53030995A patent/JP3947216B2/ja not_active Expired - Lifetime
- 1995-05-19 MX MX9605838A patent/MX9605838A/es unknown
- 1995-05-19 DK DK95918939T patent/DK0763032T3/da active
- 1995-05-19 NZ NZ285539A patent/NZ285539A/en not_active IP Right Cessation
- 1995-05-19 KR KR1019960706634A patent/KR100385027B1/ko not_active IP Right Cessation
- 1995-05-19 RO RO96-02190A patent/RO118586B1/ro unknown
- 1995-05-19 RU RU96124486A patent/RU2138496C1/ru active
- 1995-05-19 PT PT95918939T patent/PT763032E/pt unknown
- 1995-05-19 SK SK1498-96A patent/SK284495B6/sk not_active IP Right Cessation
- 1995-05-19 AU AU24671/95A patent/AU688505B2/en not_active Expired
- 1995-05-19 AT AT95918939T patent/ATE252095T1/de active
- 1995-05-19 HU HU9603236A patent/HU226460B1/hu unknown
- 1995-05-19 WO PCT/US1995/005506 patent/WO1995032197A1/en active IP Right Grant
- 1995-05-19 UA UA96124773A patent/UA52586C2/ru unknown
- 1995-05-19 CN CNB011034440A patent/CN1157390C/zh not_active Expired - Lifetime
- 1995-05-19 CN CN95194106A patent/CN1077104C/zh not_active Expired - Lifetime
- 1995-05-23 HR HR08/248,288 patent/HRP950304B1/xx not_active IP Right Cessation
- 1995-05-23 YU YU33495A patent/YU49345B/sh unknown
-
1996
- 1996-11-22 FI FI964669A patent/FI116899B/fi not_active IP Right Cessation
-
1998
- 1998-08-11 HK HK98109812A patent/HK1009045A1/xx not_active IP Right Cessation
-
2002
- 2002-04-15 HK HK02102830.8A patent/HK1041262B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK284495B6 (sk) | Spôsob výroby triazolyltryptamínových zlúčenín a medziprodukty na vykonávanie tohto spôsobu | |
| JP2834889B2 (ja) | テトラヒドロフラン抗真菌剤 | |
| AU654350B2 (en) | Benzofuran derivatives | |
| US20050101654A1 (en) | Process for the preparation of N-amino substituted heterocyclic compounds | |
| KR100214353B1 (ko) | 불소 화합물 | |
| KR20010072037A (ko) | 이미다졸 화합물 및 아데노신 데아미나아제 억제제로서의그의 용도 | |
| AU726027B2 (en) | Quaternary ammonium compounds as tachykinin antagonists | |
| KR20000023595A (ko) | 1-치환 4-시아노-1,2,3-트리아졸의 제조방법 | |
| JP2965532B2 (ja) | Ｎ−ベンジルアゾリウム誘導体 | |
| CZ296249B6 (cs) | Zpusob výroby triazolyltryptaminového derivátu | |
| JPH08283261A (ja) | ３−フェニルトリアゾール誘導体および殺虫、殺ダニ剤 | |
| JP2896949B2 (ja) | １−（４−アシルフェニル）アゾール類の製造方法 | |
| JP2961538B2 (ja) | イミダゾロンおよびイミダゾリジノン誘導体の合成中間体および製造法 | |
| AU748710B2 (en) | Imidazole compounds | |
| WO1997017338A1 (en) | Substituted 1-indolylpropyl-4-benzylpiperazine derivatives | |
| SK12392003A3 (sk) | Spôsob prípravy monohydrátu a kryštalických modifikácií flukonazolu | |
| CA2313001A1 (en) | Process for preparing triazole antimycotic compounds | |
| JP2001163892A (ja) | アゾール誘導体又はその塩 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TC4A | Change of owner's name |
Owner name: MERCK SHARP & DOHME CORP., RAHWAY, NJ, US Effective date: 20100429 |
|
| PC4A | Assignment and transfer of rights |
Owner name: SCHERING CORPORATION, KENILWORTH, NEW JERSEY, US Free format text: FORMER OWNER: MERCK SHARP & DOHME CORP., RAHWAY, NJ, US Effective date: 20121122 |
|
| TC4A | Change of owner's name |
Owner name: MERCK SHARP & DOHME CORP., RAHWAY, NJ, US Effective date: 20121122 |
|
| MK4A | Patent expired |
Expiry date: 20150519 |